Wells Fargo & Company »

Foghorn Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $34k 5.3k 6.45
2023-09-30 $20k 4.1k 5.00
2023-06-30 $60k 8.5k 7.04
2022-12-31 $34k 5.4k 6.38
2022-09-30 $3.0k 367 8.17
2022-06-30 $8.0k 562 14.23
2022-03-31 $63k 4.1k 15.34
2021-12-31 $250k 11k 22.91
2021-06-30 $0 38 0.00
2021-03-31 $30k 2.3k 13.33
2020-12-31 $76k 3.7k 20.28